TIA
CME icon

Traphagen Investment Advisors’s CME Group CME Stock Holding History

Traphagen Investment Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
48,595
+40
+0.1% +$11.1K 0.77% 19
2026
Q1 		$14.3M Buy
48,555
+19
+0% +$5.64K 1.16% 18
2025
Q4 		$13.3M Buy
48,536
+18
+0% +$4.89K 1.09% 17
2025
Q3 		$13.1M Buy
48,518
+3
+0% +$816 1.13% 17
2025
Q2 		$13.4M Buy
48,515
+2
+0% +$544 1.27% 17
2025
Q1 		$12.9M Buy
48,513
+9
+0% +$2.22K 1.34% 13
2024
Q4 		$11.3M Buy
48,504
+2
+0% +$460 1.15% 16
2024
Q3 		$10.7M Buy
48,502
+10
+0% +$2.07K 1.08% 17
2024
Q2 		$9.53M Hold
48,492
– – 1.03% 17
2024
Q1 		$10.4M Buy
48,492
+11
+0% +$2.31K 1.11% 17
2023
Q4 		$10.2M Buy
48,481
+1
+0% +$213 1.2% 19
2023
Q3 		$9.71M Buy
48,480
+2
+0% +$398 1.23% 17
2023
Q2 		$8.98M Sell
48,478
-5
-0% -$924 1.17% 16
2023
Q1 		$9.29M Buy
48,483
+9
+0% +$1.63K 1.36% 15
2022
Q4 		$8.15M Sell
48,474
-246
-0.5% -$42.8K 1.28% 15
2022
Q3 		$8.63M Buy
48,720
+5
+0% +$988 1.58% 16
2022
Q2 		$9.97M Buy
48,715
+4
+0% +$848 1.82% 15
2022
Q1 		$11.6M Buy
48,711
+277
+0.6% +$65.1K 1.87% 14
2021
Q4 		$11.1M Buy
48,434
+1
+0% +$220 1.81% 12
2021
Q3 		$9.37M Buy
48,433
+6
+0% +$1.22K 1.68% 12
2021
Q2 		$10.3M Buy
48,427
+1
+0% +$211 1.75% 15
2021
Q1 		$9.89M Buy
48,426
+4
+0% +$788 1.81% 15
2020
Q4 		$8.82M Buy
48,422
+11
+0% +$1.87K 1.59% 18
2020
Q3 		$8.1M Buy
48,411
+51
+0.1% +$8.59K 1.64% 17
2020
Q2 		$7.86M Buy
48,360
+1
+0% +$179 1.78% 14
2020
Q1 		$8.36M Buy
+48,359
New +$9.63M 2.24% 11

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Traphagen Investment Advisors's CME Position: Q2 2026 in Review

Traphagen Investment Advisors increased its CME Group (CME) stake by 0.08% in Q2 2026, buying an estimated $11.1K and bringing the position to 48,595 shares worth $10.7M. The position accounts for 0.77% of the portfolio, ranked #19.

Traphagen Investment Advisors first reported a position in CME in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.3M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Traphagen Investment Advisors held 48,595 shares of CME Group worth $10.7M as of Q2 2026.
  • Traphagen Investment Advisors bought 40 CME Group shares in Q2 2026, an estimated $11.1K.
  • CME Group made up 0.77% of Traphagen Investment Advisors's portfolio in Q2 2026, its #19 holding.
  • Traphagen Investment Advisors first reported a position in CME Group in Q1 2020 and has held it in 26 quarters since.
  • Traphagen Investment Advisors's CME Group position peaked at $14.3M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.